$SYK

AI 分析

生成于 May 18, 2026

AI Score
76/ 100
Buy$SYK

Stryker Corporation

$SYKNYSEHealthcareLarge-Cap

Stryker operates as a medical technology company offering orthopedic implants, surgical equipment, and neurotechnology products worldwide.

Market Cap
$145B
Revenue (TTM)
$22.5B
+10.5%
Net Income (TTM)
$4.2B
+14.5%
EPS (TTM)
$11.25
P/E Ratio
34.2
Dividend Yield
0.9%
52-Week Range
$325-$415
Beta
0.92
Dimension Scores
Fundamental
80
Technical
72
Sentiment
76
Risk / Reward
76
Momentum
72
FundTechSentRiskMome
Financial Health
Profitability
80strong
Growth
78moderate
Liquidity
78moderate
Solvency
75moderate
Efficiency
78moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $SYK

Free · No credit card required

免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。

探索更多

用 AI 分析任意股票

获取涵盖基本面、技术面、情绪面、风险评估和投资论点的结构化研究报告——约 60 秒完成。